Overexpression of Srebf2 increases lipotoxicity in different kind of cells, including PBCs and hepatocytes, inducing DM and non-alcoholic steatohepatitis [29,35,36,37]. The gene discussed is SREBF2; the disease is metabolic dysfunction-associated steatohepatitis.